Clinical Trial Update: A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes. [Phase 1]

View source ↗

Summary

Phase 1 study assessing drug-drug interaction between GK Activator (2) and glyburide in adults with type 2 diabetes; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GK Activator (2)
• Glyburide (glyburide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED